AcelRx (ACRX) Plans Common Stock Offering

July 17, 2013 4:04 PM EDT Send to a Friend
AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The Company expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. All of the shares to be sold in the proposed offering are to be sold by AcelRx.

Jefferies LLC and Piper Jaffray & Co. are acting as joint book-running managers for the offering, and Guggenheim Securities is acting as co-manager for the offering.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News, Equity Offerings

Related Entities

Piper Jaffray, Jefferies & Co

Add Your Comment